Cargando…

The truncated IFITM3 facilitates the humoral immune response in inactivated influenza vaccine-vaccinated mice via interaction with CD81

A single-nucleotide polymorphism (SNP) rs12252-C of interferon-induced transmembrane protein 3 (IFITM3), resulting in a truncated IFITM3 protein lacking 21 N-terminus amino acids, is associated with severe influenza infection in the Chinese population. However, the effect of IFITM3 rs12252-C on infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Qian, Liao, Xinzhong, Huang, Bi, Wang, Liangliang, Liao, Guancheng, Luo, Chuming, Wen, Simin, Fang, Shisong, Luo, Huanle, Shu, Yuelong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Influenza Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484049/ https://www.ncbi.nlm.nih.gov/pubmed/37556756 http://dx.doi.org/10.1080/22221751.2023.2246599

Ejemplares similares

A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine
por: Tzeng, Tsai-Teng, et al.
Publicado: (2023)

An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses
por: Xiong, Feifei, et al.
Publicado: (2023)

Immunodominance hierarchy after seasonal influenza vaccination
por: Sánchez-de Prada, Laura, et al.
Publicado: (2022)

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
por: Wei, Xia, et al.
Publicado: (2023)

Characterizing the dynamics of BCR repertoire from repeated influenza vaccination
por: Mai, Guoqin, et al.
Publicado: (2023)

SARS-CoV-2 detection and inactivation in water and wastewater: review on analytical methods, limitations and future research recommendations
por: Kallem, Parashuram, et al.
Publicado: (2023)

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Influenza vaccination is associated with a reduced risk of invasive aspergillosis in high-risk individuals in Taiwan: a population-based cohort study
por: Chen, Yi-Jyun, et al.
Publicado: (2022)

Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence
por: Ma, Ning, et al.
Publicado: (2023)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Gap between cognitions and behaviors among children’s guardians of influenza vaccination: The role of social influence and vaccine-related knowledge
por: Wu, Jing, et al.
Publicado: (2023)

A variant NS1 protein from H5N2 avian influenza virus suppresses PKR activation and promotes replication and virulence in mammals
por: Chung, Yun-Ting, et al.
Publicado: (2022)

Seasonal Influenza Vaccine Allocation in the Canadian Population during a Pandemic
por: Tuite, Ashleigh, et al.
Publicado: (2009)

Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
por: Zimmerman, Richard K., et al.
Publicado: (2023)

Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”
por: Hadigal, Sanjay, et al.
Publicado: (2023)

PREVALENCE OF ANTIBODIES AGAINST INFLUENZA VIRUS IN NON-VACCINATED EQUINES FROM THE BRAZILIAN PANTANAL
por: Silva, Lucas Gaíva E, et al.
Publicado: (2014)

Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials
por: Zhao, Xiahong, et al.
Publicado: (2016)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
por: Liu, Xuejie, et al.
Publicado: (2023)

Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy
por: Bianchi, Francesco Paolo, et al.
Publicado: (2023)

Parental intention to vaccinate children against seasonal influenza in the Eastern Mediterranean region: A cross-sectional study using the health belief model
por: Fadl, Noha, et al.
Publicado: (2023)

Knowledge, attitudes, concern, behaviors, and barriers associated with the readiness to receive seasonal influenza vaccine among healthcare workers in oncology setting during the COVID-19 pandemic
por: Mubarak, Sawsan, et al.
Publicado: (2023)

Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK
por: Nguyen, Van Hung, et al.
Publicado: (2023)

Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults
por: Frey, Sharon S., et al.
Publicado: (2023)

Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020
por: Lewis, Nicola S., et al.
Publicado: (2021)

Influenza virus genotype to phenotype predictions through machine learning: a systematic review: Computational Prediction of Influenza Phenotype
por: Borkenhagen, Laura K., et al.
Publicado: (2021)

Infections with highly pathogenic avian influenza A virus (HPAIV) H5N8 in harbor seals at the German North Sea coast, 2021
por: Postel, Alexander, et al.
Publicado: (2022)

Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells
por: Yu, Jiapei, et al.
Publicado: (2022)

Emergence, prevalence, and evolution of H5N8 avian influenza viruses in central China, 2020
por: Li, Xiang, et al.
Publicado: (2021)

Human infection with avian-origin H5N6 influenza a virus after exposure to slaughtered poultry
por: Li, Jun, et al.
Publicado: (2022)

Highly pathogenic avian influenza (A/H5N1) virus outbreaks in Lesotho, May 2021
por: Makalo, Mabusetsa R.J., et al.
Publicado: (2022)

A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity
por: Wang, Xin, et al.
Publicado: (2022)

Exploring surface water as a transmission medium of avian influenza viruses – systematic infection studies in mallards
por: Ahrens, Ann Kathrin, et al.
Publicado: (2022)

Novel H5N6 reassortants bearing the clade 2.3.4.4b HA gene of H5N8 virus have been detected in poultry and caused multiple human infections in China
por: Gu, Wenli, et al.
Publicado: (2022)

Pathogenesis and transmission of human seasonal and swine-origin A(H1) influenza viruses in the ferret model
por: Pulit-Penaloza, Joanna A., et al.
Publicado: (2022)

Assessing potential pathogenicity of novel highly pathogenic avian influenza (H5N6) viruses isolated from Mongolian wild duck feces using a mouse model
por: Duong, Bao Tuan, et al.
Publicado: (2022)

Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China
por: Cui, Pengfei, et al.
Publicado: (2022)

A case of human infection by H3N8 influenza virus
por: Tan, Xin, et al.
Publicado: (2022)

Clinical features of the first critical case of acute encephalitis caused by the avian influenza A (H5N6) virus
por: Zhang, Libing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdrv56p4hh10ek51a1o2s9acc9